Efficacy of EBPSI on Future Suicide Risk Among Adolescent Suicide Attempters

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-18
SponsorUniversity of Pittsburgh

About this trial

Our study is designed to study the efficacy of an Electronic based psycho-social intervention targeting healthy coping and problem solving skills to mitigate suicidal behaviour. This would integrate existing systems and bridge the gap in accessibility to care for suicidal behaviour.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

All adolescents who have attempted suicide within the last thirty days and presented to the study site

Between ages of 12-18 years

Participants of all gender will be included

Medically stable patients who have stable blood pressure, breathing rates without fever, and intact orientation to time, place, and person

Disqualifiers

A current or a lifetime diagnosis of psychosis. We will confirm the same using a detailed clinical interview according to ICD-10 diagnostic guidelines.

A history of mental retardation and any neurological condition causing cognitive impairment.

A diagnosis of substance dependence as confirmed by M.I.N.I. KID 6.0 over the last six months. We will include those with tobacco dependence.

A diagnosis of serious medical illness like end-stage cancer, AIDS, less than a month following acute cardiovascular and cerebrovascular events.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Electronic Based Psychosocial Intervention (EBPSI)

    Behavioral

    Electronic based Psycho-social Intervention (EBPSI) described as video based telepsychiatry sessions targeted on brief intervention and coping skills; with a total of 5 sessions on days 10, 30, 45, 60 and 90 after baseline intervention.

Treatment groups

168 Participants
are divided into 2 treatment groups
Group A: Electronic Based Psychosocial Intervention (EBPSI)Experimental treatment 1 intervention
Group B: Treatment as UsualActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Persistent Suicide Ideation

Change in intervention arm as compared to TAU on persistent suicidal ideation using the Columbia Suicide Severity Rating Scale (C-SSRS). the ideation ranges from 0-5 on this scale.

Time frame
At baseline and 1,3, 6 and 12 months after the baseline intervention.
2

Suicide attempts

Change in intervention arm as compared to TAU on number of suicide attempts. Minimum attempts can be 0 and maximum can be infinity.

Time frame
At baseline and 1,3, 6 and 12 months after the baseline intervention.

Secondary outcomes

1

Depression

Change in depression in intervention group as compared to TAU using Beck Depression Inventory (BDI). The minimum score is 0 and maximum is 63.

Time frame
At baseline and 1,3, 6 and 12 months after the baseline intervention.
2

Acceptability of Intervention Measure (AIM)

To assess the acceptability of EBPSI By using acceptability of Intervention Measure and Intervention Appropriateness Measure (IAM). The minimum score is 0 and maximum is 16.

Time frame
At baseline and 1,3, 6 and 12 months after the baseline intervention.
3

Feasibility of Intervention Measure (FIM)

To assess the feasibility of intervention by using Feasibility of Intervention Measure (FIM). The minimum score is 0 and maximum is 16.

Time frame
At baseline and 1,3, 6 and 12 months after the baseline intervention.
4

Attribution Style

To compare change in attribution styles of intervention and TAU group using Children's Attributional Style Questionnaire (Minimum score 5 and maximum score is 35).

Time frame
At baseline and 1,3, 6 and 12 months after the baseline intervention.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Pittsburgh

Lead sponsor

Fogarty International Center of the National Institute of Health

Collaborator

St.John's Medical College and Hospital

Collaborator